Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bnp Paribas Investment Partners
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bnp Paribas Investment Partners
from 13F filings
Historical chart of Bnp Paribas Investment Partners investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Bnp Paribas Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Bnp Paribas Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $7.0M | 4.8M | 1.48 |
| 2025-06-30 | $6.4M | 5.0M | 1.30 |
| 2025-03-31 | $5.7M | 5.0M | 1.15 |
| 2024-12-31 | $5.3M | 5.0M | 1.06 |
| 2024-09-30 | $5.8M | 5.0M | 1.17 |
| 2024-06-30 | $5.4M | 5.0M | 1.08 |
| 2024-03-31 | $4.7M | 5.0M | 0.94 |
More positions owned by Bnp Paribas Investment Partners
View all positions for Bnp Paribas Investment Partners
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1